Outcome Analysis of Patients with pN2 Oral Cavity Cancer
Authors:
- Chun-Ta LiaoCLChun-Ta Liao
- Shiang-Fu HuangSHShiang-Fu Huang
- I-How ChenICI-How Chen
- Chung-Jan KangCKChung-Jan Kang
- Chien-Yu LinCLChien-Yu Lin
- Kang-Hsing FanKFKang-Hsing Fan
- Hung-Ming WangHWHung-Ming Wang
- Shu-Hang NgSNShu-Hang Ng
- Chuen HsuehCHChuen Hsueh
- Li-Yu LeeLLLi-Yu Lee
- Chung-Kan TsaoCTChung-Kan Tsao
- Tzu-Chen YenTYTzu-Chen Yen
- 5 February 2010
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 17 (4) , 1118-1126
Abstract
The American Joint Committee on Cancer staging system suggests that squamous-cell carcinoma of the oral cavity (OSCC) with pN2 should be classified as stage IVA. The objective of the current study was to determine the outcome of patients with pN2 OSCC cancer according to different T status. Between January 1996 and September 2007, a total of 270 patients with pN2 OSCC cancer were analyzed. All participants had a follow-up of at least 2 years or were censored on the date of last follow-up. The outcome measures for this study were the 5-year rates of locoregional control, distant metastases, and survival. Five-year disease-specific survival and overall survival rates in pT1 (n = 9), pT2 (n = 98), pT3 (n = 70), and pT4 (n = 93) patients were 78%, 66%, 49%, 35% (P = 0.0031), and 78%, 52%, 35%, 23% (P = 0.0001), respectively. Multivariable analysis revealed that pT3-4, level IV/V metastases, extracapsular spread, and poor differentiation were independent risk factors for 5-year disease-specific survival in the entire study cohort. Specific independent prognostic factors for 5-year disease-specific survival according to T stage were found. The results of this study suggest that patients with pN2 OSCC cancer have different outcomes and prognostic factors according to their T status. In the light of these findings, treatment strategies may be quite different.Keywords
This publication has 16 references indexed in Scilit:
- Lymph node density is a significant predictor of outcome in patients with oral cancerCancer, 2009
- Analysis of Risk Factors of Predictive Local Tumor Control in Oral Cavity CancerAnnals of Surgical Oncology, 2007
- Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavityCancer, 2007
- Survival in squamous cell carcinoma of the oral cavityCancer, 2007
- Surgical outcome of T4a and resected T4b oral cavity cancerCancer, 2006
- Histopathological prognosticators in oral and oropharyngeal squamous cell carcinomaOral Oncology, 2006
- Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)Head & Neck, 2005
- Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck CancerNew England Journal of Medicine, 2004
- Cisplatin, tegafur, and leucovorinCancer, 2002
- Combined postoperative radiotherapy and Weekly Cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996